VMP 42295211000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Hydroxychloroquine 200mg tablets
BNF code 1001030C0AAAAAA
Virtual Therapeutic Moiety Hydroxychloroquine
Date identifier became valid 29 Sep 2023
Previous product identifier 330037008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Hydroxychloroquine sulfate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Hydroxychloroquine 200mg tablets (A A H Pharmaceuticals Ltd)
Hydroxychloroquine 200mg tablets (Accord-UK Ltd)
Hydroxychloroquine 200mg tablets (Alliance Healthcare (Distribution) Ltd)
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd)
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd)
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd)
Hydroxychloroquine 200mg tablets (Medihealth (Northern) Ltd)
Hydroxychloroquine 200mg tablets (Phoenix Healthcare Distribution Ltd)
Hydroxychloroquine 200mg tablets (Sigma Pharmaceuticals Plc)
Hydroxychloroquine 200mg tablets (Zentiva Pharma UK Ltd)
Quinoric 200mg tablets (Bristol Laboratories Ltd)
Virtual Medicinal Product Packs
Hydroxychloroquine 200mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_6.3.0_20240624000001, imported on 24th June 2024 at 05:06:11.

Feedback